{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T02:03:18Z","timestamp":1794362598554,"version":"4.9.0"},"reference-count":214,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"am","delay-in-days":710,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35GM095467"],"award-info":[{"award-number":["R35GM095467"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K99HL153673"],"award-info":[{"award-number":["K99HL153673"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.smim.2022.101597","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T01:11:58Z","timestamp":1644973918000},"page":"101597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"special_numbering":"C","title":["E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition"],"prefix":"10.1016","volume":"59","author":[{"given":"Charles N.","family":"Serhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephania","family":"Libreros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Nshimiyimana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.smim.2022.101597_bib0005","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jmv.26232","article-title":"The cytokine storm and COVID-19","volume":"93","author":"Hu","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.smim.2022.101597_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173644","article-title":"Treatment for COVID-19: an overview","volume":"889","author":"Stasi","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.smim.2022.101597_bib0015","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/ni.3790","article-title":"A guiding map for inflammation","volume":"18","author":"Netea","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2022.101597_bib0020","series-title":"Fundamentals of Inflammation","author":"Serhan","year":"2010"},{"issue":"7","key":"10.1016\/j.smim.2022.101597_bib0025","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1172\/JCI97945","article-title":"Leukotriene biosynthetic enzymes as therapeutic targets","volume":"128","author":"Haeggstrom","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.smim.2022.101597_bib0030","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1126\/science.6301011","article-title":"Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation","volume":"220","author":"Samuelsson","year":"1983","journal-title":"Science"},{"issue":"7503","key":"10.1016\/j.smim.2022.101597_bib0035","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.smim.2022.101597_bib0040","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.20020760","article-title":"Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter pro-inflammation signals","volume":"196","author":"Serhan","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2022.101597_bib0045","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nri2294","article-title":"Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators","volume":"8","author":"Serhan","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.smim.2022.101597_bib0050","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000071559","article-title":"Regulation of vascular permeability by neutrophils in acute inflammation","volume":"83","author":"Lindbom","year":"2003","journal-title":"Chem. Immunol. Allergy"},{"key":"10.1016\/j.smim.2022.101597_bib0055","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature11042","article-title":"Infection regulates pro-resolving mediators that lower antibiotic requirements","volume":"484","author":"Chiang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.smim.2022.101597_bib0060","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.4049\/jimmunol.174.7.4345","article-title":"Molecular circuits of resolution: formation and actions of resolvins and protectins","volume":"174","author":"Bannenberg","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2022.101597_bib0065","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/89759","article-title":"Lipid mediator class switching during acute inflammation: signals in resolution","volume":"2","author":"Levy","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2022.101597_bib0070","doi-asserted-by":"crossref","first-page":"14677","DOI":"10.1074\/jbc.M300218200","article-title":"Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood and glial cells: autacoids in anti-inflammation","volume":"278","author":"Hong","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2022.101597_bib0075","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1084\/jem.20081880","article-title":"Maresins: novel macrophage mediators with potent anti-inflammatory and pro-resolving actions","volume":"206","author":"Serhan","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2022.101597_bib0080","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3389\/fphar.2019.00891","article-title":"Regulation of apoptotic cell clearance during resolution of inflammation","volume":"10","author":"Arienti","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.smim.2022.101597_bib0085","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1182\/blood-2012-04-423525","article-title":"Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators","volume":"120","author":"Dalli","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.smim.2022.101597_bib0090","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41467-017-02538-5","article-title":"Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity","volume":"9","author":"Werz","year":"2018","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.smim.2022.101597_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108247","article-title":"Staphylococcus aureus-derived alpha-hemolysin evokes generation of specialized pro-resolving mediators promoting inflammation resolution","volume":"33","author":"Jordan","year":"2020","journal-title":"Cell Rep."},{"issue":"46","key":"10.1016\/j.smim.2022.101597_bib0100","doi-asserted-by":"crossref","first-page":"23254","DOI":"10.1073\/pnas.1907490116","article-title":"HMGB1-C1q complexes regulate macrophage function by switching between leukotriene and specialized proresolving mediator biosynthesis","volume":"116","author":"Liu","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2022.101597_bib0105","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1084\/jem.192.8.1197","article-title":"Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing","volume":"192","author":"Serhan","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2022.101597_bib0110","first-page":"227","article-title":"Cell-cell interaction in the transcellular biosynthesis of novel omega-3-derived lipid mediators","volume":"341","author":"Chiang","year":"2006","journal-title":"Methods Mol. Biol."},{"issue":"6","key":"10.1016\/j.smim.2022.101597_bib0115","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100540R","article-title":"High levels of eicosanoids and docosanoids in the lungs of intubated COVID-19 patients","volume":"35","author":"Archambault","year":"2021","journal-title":"FASEB J."},{"key":"10.1016\/j.smim.2022.101597_bib0120","article-title":"Severe SARS-CoV-2 infection in humans is defined by a shift in the serum lipidome resulting in dysregulation of eicosanoid immune mediators","author":"Schwarz","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.smim.2022.101597_bib0125","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1161\/CIRCRESAHA.121.319142","article-title":"Disrupted resolution mechanisms favor altered phagocyte responses in Covid-19","volume":"129","author":"Koenis","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.smim.2022.101597_bib0130","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiab632","article-title":"Serum levels of pro-inflammatory lipid mediators and specialised pro-resolving molecules are increased in SARS-CoV-2 patients and correlate with markers of the adaptive immune response","author":"Turnbull","year":"2022","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.smim.2022.101597_bib0135","first-page":"14.26.1","article-title":"Metabolomics-lipidomics of eicosanoids and docosanoids generated by phagocytes","volume":"95","author":"Yang","year":"2011","journal-title":"Curr. Protoc. Immunol. Suppl"},{"key":"10.1016\/j.smim.2022.101597_bib0140","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0076-6879(07)32012-0","article-title":"Mediator lipidomics: search algorithms for eicosanoids, resolvins and protectins","volume":"432","author":"Serhan","year":"2007","journal-title":"Meth. Enzymol."},{"key":"10.1016\/j.smim.2022.101597_bib0145","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/rcm.2798","article-title":"Identification of endogenous resolvin E1 and other lipid mediators derived from eicosapentaenoic acid via electrospray low energy tandem mass spectrometry: spectra and fragmentation mechanisms","volume":"21","author":"Lu","year":"2007","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.smim.2022.101597_bib0150","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jasms.2006.09.002","article-title":"Resolvin D1, protectin D1, and related docosahexaenoic acid-derived products: analysis via electrospray\/low energy tandem mass spectrometry based on spectra and fragmentation mechanisms","volume":"18","author":"Hong","year":"2007","journal-title":"J. Am. Soc. Mass Spectrom."},{"issue":"2","key":"10.1016\/j.smim.2022.101597_bib0155","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4049\/jimmunol.2001025","article-title":"Cutting edge: severe SARS-CoV-2 infection in humans is defined by a shift in the serum lipidome, resulting in dysregulation of eicosanoid immune mediators","volume":"206","author":"Schwarz","year":"2021","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.smim.2022.101597_bib0160","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/all.14595","article-title":"Dexamethasone, pro-resolving lipid mediators and resolution of inflammation in COVID-19","volume":"76","author":"Andreakos","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.smim.2022.101597_bib0165","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10555-020-09889-4","article-title":"Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?","volume":"39","author":"Panigrahy","year":"2020","journal-title":"Cancer Metastasis Rev."},{"issue":"4","key":"10.1016\/j.smim.2022.101597_bib0170","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202001952R","article-title":"Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages","volume":"35","author":"Recchiuti","year":"2021","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.smim.2022.101597_bib0175","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3945\/ajcn.115.116384","article-title":"Specialized proresolving lipid mediators in humans with the metabolic syndrome after n-3 fatty acids and aspirin","volume":"102","author":"Barden","year":"2015","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.smim.2022.101597_bib0180","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.plefa.2017.08.007","article-title":"Circulating inflammation-resolving lipid mediators RvD1 and DHA are decreased in patients with acutely symptomatic carotid disease","volume":"125","author":"Bazan","year":"2017","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.smim.2022.101597_bib0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prostaglandins.2018.03.002","article-title":"The effect of n-3 fatty acids and coenzyme Q10 supplementation on neutrophil leukotrienes, mediators of inflammation resolution and myeloperoxidase in chronic kidney disease","volume":"136","author":"Barden","year":"2018","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.smim.2022.101597_bib0190","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1515\/cclm-2021-0644","article-title":"Quantitative profiling of inflammatory and pro-resolving lipid mediators in human adolescents and mouse plasma using UHPLC-MS\/MS","volume":"59","author":"Hartling","year":"2021","journal-title":"Clin. Chem. Lab. Med."},{"issue":"2","key":"10.1016\/j.smim.2022.101597_bib0195","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.clnu.2015.04.004","article-title":"A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease","volume":"35","author":"Mas","year":"2016","journal-title":"Clin. Nutr. (Edinburgh, Scotland)"},{"key":"10.1016\/j.smim.2022.101597_bib0200","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1373\/clinchem.2012.190199","article-title":"Resolvins D.1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation","volume":"58","author":"Mas","year":"2012","journal-title":"Clin. Chem."},{"issue":"3","key":"10.1016\/j.smim.2022.101597_bib0205","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/metabo11030137","article-title":"Collection and storage of human plasma for measurement of oxylipins","volume":"11","author":"Polinski","year":"2021","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.smim.2022.101597_bib0210","doi-asserted-by":"crossref","first-page":"20128","DOI":"10.1038\/s41598-020-75353-6","article-title":"The relationship between specialized pro-resolving lipid mediators, morbid obesity and weight loss after bariatric surgery","volume":"10","author":"Schulte","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.smim.2022.101597_bib0215","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1194\/jlr.M045583","article-title":"Short-term n-3 fatty acid supplementation but not aspirin increases plasma proresolving mediators of inflammation","volume":"55","author":"Barden","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.smim.2022.101597_bib0220","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1476-511X-12-89","article-title":"High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation","volume":"12","author":"Weiss","year":"2013","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.smim.2022.101597_bib0225","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.plefa.2019.07.001","article-title":"Effect of weight loss on neutrophil resolvins in the metabolic syndrome","volume":"148","author":"Barden","year":"2019","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.smim.2022.101597_bib0230","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.plefa.2016.03.004","article-title":"Specialised pro-resolving mediators of inflammation in inflammatory arthritis","volume":"107","author":"Barden","year":"2016","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"2","key":"10.1016\/j.smim.2022.101597_bib0235","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1530\/REP-14-0549","article-title":"Effects of maternal n-3 fatty acid supplementation on placental cytokines, pro-resolving lipid mediators and their precursors","volume":"149","author":"Keelan","year":"2015","journal-title":"Reproduction"},{"issue":"6","key":"10.1016\/j.smim.2022.101597_bib0240","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13393","article-title":"Metabolipidomic profiling reveals an age-related deficiency of skeletal muscle pro-resolving mediators that contributes to maladaptive tissue remodeling","volume":"20","author":"Markworth","year":"2021","journal-title":"Aging Cell"},{"issue":"6","key":"10.1016\/j.smim.2022.101597_bib0245","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100078R","article-title":"Local shifts in inflammatory and resolving lipid mediators in response to tendon overuse","volume":"35","author":"Markworth","year":"2021","journal-title":"FASEB J."},{"key":"10.1016\/j.smim.2022.101597_bib0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2020.102219","article-title":"Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation","volume":"164","author":"Lamon-Fava","year":"2021","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.smim.2022.101597_bib0255","doi-asserted-by":"crossref","first-page":"R1281","DOI":"10.1152\/ajpregu.00128.2013","article-title":"Human inflammatory and resolving lipid mediator responses to resistance exercise and ibuprofen treatment","volume":"305","author":"Markworth","year":"2013","journal-title":"Am. J. Physiol. Regul. Integr. Compar. Physiol."},{"issue":"1","key":"10.1016\/j.smim.2022.101597_bib0260","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1038\/s41598-021-82606-5","article-title":"Immunomodulatory lipid mediator profiling of cerebrospinal fluid following surgery in older adults","volume":"11","author":"Terrando","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.smim.2022.101597_bib0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171249","article-title":"Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis","volume":"12","author":"Eickmeier","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2022.101597_bib0270","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.plefa.2018.04.004","article-title":"The effects of alcohol on plasma lipid mediators of inflammation resolution in patients with Type 2 diabetes mellitus","volume":"133","author":"Barden","year":"2018","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.smim.2022.101597_bib0275","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1017\/S0007114517002914","article-title":"Effects of prenatal n-3 fatty acid supplementation on offspring resolvins at birth and 12 years of age: a double-blind, randomised controlled clinical trial","volume":"118","author":"See","year":"2017","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.smim.2022.101597_bib0280","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3389\/fphar.2018.01582","article-title":"The protectin family of specialized pro-resolving mediators: potent immunoresolvents enabling innovative approaches to target obesity and diabetes","volume":"9","author":"Hansen","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.smim.2022.101597_bib0285","article-title":"First total syntheses of the pro-resolving lipid mediators 7(S),13(R),20(S)-Resolvin T1 and 7(S),13(R)-Resolvin T4","volume":"61","author":"Rodriguez","year":"2020","journal-title":"Tetrahedron Lett."},{"issue":"20","key":"10.1016\/j.smim.2022.101597_bib0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.tetlet.2020.151857","article-title":"First total synthesis of the pro-resolving lipid mediator 7(S),12(R),13(S)-Resolvin T2 and its 13(R)-epimer","volume":"61","author":"Rodriguez","year":"2020","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.smim.2022.101597_bib0295","article-title":"Resolvin T-series reduce neutrophil extracellular traps","author":"Chiang","year":"2021","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.smim.2022.101597_bib0300","doi-asserted-by":"crossref","first-page":"L904","DOI":"10.1152\/ajplung.00370.2014","article-title":"Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent","volume":"308","author":"Orr","year":"2015","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.smim.2022.101597_bib0305","article-title":"A new E-series resolvin: RvE4 stereochemistry and function in efferocytosis of inflammation-resolution","volume":"11","author":"Libreros","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2022.101597_bib0310","doi-asserted-by":"crossref","DOI":"10.1002\/JLB.3CE0118-032R","article-title":"Commercial scale production of RvD4 opens the resolving door to new research","author":"Edin","year":"2018","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.smim.2022.101597_bib0315","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.704163","article-title":"Safety and preliminary efficacy of a novel host-modulatory therapy for reducing gingival inflammation","volume":"12","author":"Hasturk","year":"2021","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.smim.2022.101597_bib0320","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41581-021-00454-y","article-title":"Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function","volume":"17","author":"Brennan","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.smim.2022.101597_bib0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113965","article-title":"Therapeutic potential of pro-resolving mediators in diabetic kidney disease","volume":"178","author":"Vartak","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.smim.2022.101597_bib0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2020.102218","article-title":"Altered tissue specialized pro-resolving mediators in chronic rhinosinusitis","volume":"164","author":"Vickery","year":"2021","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"6","key":"10.1016\/j.smim.2022.101597_bib0335","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jaci.2005.02.029","article-title":"Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis","volume":"115","author":"P\u00e9rez-Novo","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"issue":"25","key":"10.1016\/j.smim.2022.101597_bib0340","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1056\/NEJMra1008153","article-title":"n-3 fatty acids in cardiovascular disease","volume":"364","author":"De Caterina","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.smim.2022.101597_bib0345","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s43016-021-00289-7","article-title":"Bang and Dyerberg\u2019s omega-3 discovery turns fifty","volume":"2","author":"Harris","year":"2021","journal-title":"Nat. Food"},{"issue":"1","key":"10.1016\/j.smim.2022.101597_bib0350","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.smim.2022.101597_bib0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107703","article-title":"Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?","volume":"219","author":"Darwesh","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.smim.2022.101597_bib0360","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1084\/jem.20042031","article-title":"Stereochemical assignment, anti-inflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1","volume":"201","author":"Arita","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2022.101597_bib0365","series-title":"Robbins Pathologic Basis of Disease","author":"Cotran","year":"1999"},{"key":"10.1016\/j.smim.2022.101597_bib0370","series-title":"Methods in Molecular Biology","article-title":"Cell-cell interactions: methods and protocols","author":"Colgan","year":"2006"},{"key":"10.1016\/j.smim.2022.101597_bib0375","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood-2007-11-122598","article-title":"Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets","volume":"112","author":"Dona","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.smim.2022.101597_bib0380","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbrc.2005.07.181","article-title":"The contributions of aspirin and microbial oxygenase to the biosynthesis of anti-inflammatory resolvins: novel oxygenase products from omega-3 polyunsaturated fatty acids","volume":"338","author":"Arita","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.smim.2022.101597_bib0385","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1172\/JCI42545","article-title":"Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation","volume":"121","author":"Oh","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.smim.2022.101597_bib0390","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.chembiol.2006.09.011","article-title":"Resolvin E2: Identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis","volume":"13","author":"Tjonahen","year":"2006","journal-title":"Chem. Biol."},{"issue":"14","key":"10.1016\/j.smim.2022.101597_bib0395","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd1453","article-title":"Agonist anti-ChemR23 mAb reduces tissue neutrophil accumulation and triggers chronic inflammation resolution","volume":"7","author":"Trilleaud","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.smim.2022.101597_bib0400","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nature05877","article-title":"Resolvin E1 and protectin D1 activate inflammation-resolution programmes","volume":"447","author":"Schwab","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.smim.2022.101597_bib0405","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1096\/fj.05-4724fje","article-title":"RvE1 protects from local inflammation and osteoclast mediated bone destruction in periodontitis","volume":"20","author":"Hasturk","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.smim.2022.101597_bib0410","doi-asserted-by":"crossref","first-page":"22847","DOI":"10.1074\/jbc.M603766200","article-title":"Metabolic inactivation of resolvin E1 and stabilization of its anti-inflammatory actions","volume":"281","author":"Arita","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.smim.2022.101597_bib0415","doi-asserted-by":"crossref","first-page":"10525","DOI":"10.1074\/jbc.M112.340612","article-title":"Identification and structure determination of novel anti-inflammatory mediator resolvin E3, 17,18-dihydroxyeicosapentaenoic acid","volume":"287","author":"Isobe","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.smim.2022.101597_bib0420","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1084\/jem.20132011","article-title":"18-HEPE, an n-3 fatty acid metabolite released by macrophages, prevents pressure overload-induced maladaptive cardiac remodeling","volume":"211","author":"Endo","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2022.101597_bib0425","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax4895","article-title":"Resolution metabolomes activated by hypoxic environment","volume":"5","author":"Norris","year":"2019","journal-title":"Sci. Adv."},{"issue":"12","key":"10.1016\/j.smim.2022.101597_bib0430","article-title":"Human lipoxygenase isoforms form complex patterns of double and triple oxygenated compounds from eicosapentaenoic acid","volume":"1865","author":"Kutzner","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"4","key":"10.1016\/j.smim.2022.101597_bib0435","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1021\/acs.joc.0c02913","article-title":"Stereoselective synthesis and structural confirmation of the specialized pro-resolving mediator resolvin E4","volume":"86","author":"Reinertsen","year":"2021","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.smim.2022.101597_bib0440","series-title":"The Neutrophil an Emergenging Regulator of Inflammatory and Immune Response","author":"Cassatella","year":"2003"},{"issue":"7","key":"10.1016\/j.smim.2022.101597_bib0445","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/ni.2921","article-title":"Neutrophils at work","volume":"15","author":"Nauseef","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2022.101597_bib0450","article-title":"Cerebrospinal fluid profile of lipid mediators in Alzheimer\u2019s disease","author":"Do","year":"2021","journal-title":"Res. Sq."},{"issue":"1","key":"10.1016\/j.smim.2022.101597_bib0455","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/ni.3320","article-title":"Tissue biology perspective on macrophages","volume":"17","author":"Okabe","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2022.101597_bib0460","doi-asserted-by":"crossref","first-page":"16172","DOI":"10.1021\/acssuschemeng.0c04793","article-title":"Discovery and engineering of a microbial double-oxygenating lipoxygenase for synthesis of dihydroxy fatty acids as specialized proresolving mediators","volume":"8","author":"Lee","year":"2020","journal-title":"ACS Sustain. Chem. Eng."},{"key":"10.1016\/j.smim.2022.101597_bib0465","doi-asserted-by":"crossref","first-page":"9475","DOI":"10.1073\/pnas.92.21.9475","article-title":"Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions","volume":"92","author":"Cl\u00e0ria","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.smim.2022.101597_bib0470","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1038\/s41467-020-16080-4","article-title":"N-AS-triggered SPMs are direct regulators of microglia in a model of Alzheimer\u2019s disease","volume":"11","author":"Lee","year":"2020","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.smim.2022.101597_bib0475","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nm.3911","article-title":"Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections","volume":"21","author":"Dalli","year":"2015","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.smim.2022.101597_bib0480","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bbalip.2014.08.012","article-title":"5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease","volume":"1851","author":"Radmark","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.smim.2022.101597_bib0485","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1007\/s11064-020-03090-3","article-title":"Phosphorylation of 5-LOX: the potential set-point of inflammation","volume":"45","author":"He","year":"2020","journal-title":"Neurochem. Res."},{"issue":"5","key":"10.1016\/j.smim.2022.101597_bib0490","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.4049\/jimmunol.181.5.3515","article-title":"Phosphorylation of 5-lipoxygenase at ser523 by protein kinase A determines whether pioglitazone and atorvastatin induce proinflammatory leukotriene B4 or anti-inflammatory 15-epi-lipoxin a4 production","volume":"181","author":"Ye","year":"2008","journal-title":"J. Immunol."},{"issue":"21","key":"10.1016\/j.smim.2022.101597_bib0495","doi-asserted-by":"crossref","first-page":"7671","DOI":"10.1073\/pnas.0409271102","article-title":"Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis","volume":"102","author":"Arita","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.smim.2022.101597_bib0500","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1084\/jem.20150381","article-title":"Resolvin E1 inhibits dendritic cell migration in the skin and attenuates contact hypersensitivity responses","volume":"212","author":"Sawada","year":"2015","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.smim.2022.101597_bib0505","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.4049\/jimmunol.1600859","article-title":"Resolvin E1 reverses experimental periodontitis and dysbiosis","volume":"197","author":"Lee","year":"2016","journal-title":"J. Immunol."},{"issue":"50","key":"10.1016\/j.smim.2022.101597_bib0510","doi-asserted-by":"crossref","first-page":"18433","DOI":"10.1523\/JNEUROSCI.4192-11.2011","article-title":"Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1\/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: distinct roles of resolvin D1, D2, and E1","volume":"31","author":"Park","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.smim.2022.101597_bib0515","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.585530","article-title":"Maresin-1 and resolvin E1 promote regenerative properties of periodontal ligament stem cells under inflammatory conditions","volume":"11","author":"Albuquerque-Souza","year":"2020","journal-title":"Front. Immunol."},{"issue":"Suppl. 3","key":"10.1016\/j.smim.2022.101597_bib0520","first-page":"S112","article-title":"Use of specialized pro-resolving mediators to alleviate cold platelet storage lesion","volume":"60","author":"Reddoch-Cardenas","year":"2020","journal-title":"Transfusion"},{"issue":"22","key":"10.1016\/j.smim.2022.101597_bib0525","doi-asserted-by":"crossref","first-page":"6970","DOI":"10.3390\/molecules26226970","article-title":"Role of specialized pro-resolving mediators in modifying host defense and decreasing bacterial virulence","volume":"26","author":"Thornton","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.smim.2022.101597_bib0530","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.3389\/fimmu.2020.02080","article-title":"RvE1 attenuates polymicrobial sepsis-induced cardiac dysfunction and enhances bacterial clearance","volume":"11","author":"Chen","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2022.101597_bib0535","doi-asserted-by":"crossref","first-page":"H153","DOI":"10.1152\/ajpheart.01057.2009","article-title":"Resolvin E1 protects the rat heart against reperfusion injury","volume":"299","author":"Keyes","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.smim.2022.101597_bib0540","doi-asserted-by":"crossref","first-page":"718","DOI":"10.4049\/jimmunol.1601543","article-title":"Neutrophil resolvin E1 receptor expression and function in type 2 diabetes","volume":"198","author":"Freire","year":"2017","journal-title":"J. Immunol."},{"issue":"32","key":"10.1016\/j.smim.2022.101597_bib0545","doi-asserted-by":"crossref","first-page":"14298","DOI":"10.1073\/pnas.0914730107","article-title":"Resolvin E1-induced intestinal alkaline phosphatase promotes resolution of inflammation through LPS detoxification","volume":"107","author":"Campbell","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"17","key":"10.1016\/j.smim.2022.101597_bib0550","doi-asserted-by":"crossref","first-page":"9477","DOI":"10.1073\/pnas.1921335117","article-title":"Resolvin E1 is a pro-repair molecule that promotes intestinal epithelial wound healing","volume":"117","author":"Quiros","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.smim.2022.101597_bib0555","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.4049\/jimmunol.1004007","article-title":"NK cells are effectors for resolvin E1 in the timely resolution of allergic airway inflammation","volume":"186","author":"Haworth","year":"2011","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.smim.2022.101597_bib0560","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1096\/fj.08-125674","article-title":"Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins","volume":"23","author":"Gonzalez-Periz","year":"2009","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.smim.2022.101597_bib0565","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.2353\/ajpath.2010.091082","article-title":"Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis","volume":"177","author":"Ho","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.smim.2022.101597_bib0570","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1084\/jem.20170681","article-title":"Resolvins suppress tumor growth and enhance cancer therapy","volume":"215","author":"Sulciner","year":"2018","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.smim.2022.101597_bib0575","doi-asserted-by":"crossref","first-page":"11873","DOI":"10.1038\/s41598-018-30373-1","article-title":"Resolvin E1 attenuates murine psoriatic dermatitis","volume":"8","author":"Sawada","year":"2018","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.smim.2022.101597_bib0580","doi-asserted-by":"crossref","first-page":"e1316","DOI":"10.1371\/journal.pone.0001316","article-title":"Candida albicans modulates host defense by biosynthesizing the pro-resolving mediator resolvin E1","volume":"2","author":"Haas-Stapleton","year":"2007","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.smim.2022.101597_bib0585","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4049\/jimmunol.1003456","article-title":"Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1","volume":"186","author":"Rajasagi","year":"2011","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.smim.2022.101597_bib0590","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nm.2123","article-title":"Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions","volume":"16","author":"Xu","year":"2010","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.smim.2022.101597_bib0595","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/CIRCRESAHA.117.312472","article-title":"Impaired production and diurnal regulation of vascular RvDn-3 DPA increase systemic inflammation and cardiovascular disease","volume":"122","author":"Colas","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.smim.2022.101597_bib0600","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jss.2019.01.038","article-title":"Fish oil increases specialized pro-resolving lipid mediators in PAD (The OMEGA-PAD II trial)","volume":"238","author":"Ramirez","year":"2019","journal-title":"J. Surg. Res."},{"issue":"3","key":"10.1016\/j.smim.2022.101597_bib0605","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/mi.2015.99","article-title":"Human milk proresolving mediators stimulate resolution of acute inflammation","volume":"9","author":"Arnardottir","year":"2016","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.smim.2022.101597_bib0610","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.94463","article-title":"Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli-driven acute inflammation","volume":"3","author":"Motwani","year":"2018","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.smim.2022.101597_bib0615","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00213-017-4774-7","article-title":"Resolvin E1\/E2 ameliorate lipopolysaccharide-induced depression-like behaviors via ChemR23","volume":"235","author":"Deyama","year":"2018","journal-title":"Psychopharmacology (Berl.)"},{"issue":"4","key":"10.1016\/j.smim.2022.101597_bib0620","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1021\/acsmedchemlett.9b00596","article-title":"Design and synthesis of benzene congeners of resolvin E2, a proresolving lipid mediator, as its stable equivalents","volume":"11","author":"Murakami","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"issue":"11","key":"10.1016\/j.smim.2022.101597_bib0625","doi-asserted-by":"crossref","first-page":"12750","DOI":"10.1096\/fj.201900283R","article-title":"Resolvin E3 attenuates allergic airway inflammation via the interleukin-23-interleukin-17A pathway","volume":"33","author":"Sato","year":"2019","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.smim.2022.101597_bib0630","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jphs.2018.09.006","article-title":"Resolvin E3 attenuates lipopolysaccharide-induced depression-like behavior in mice","volume":"138","author":"Deyama","year":"2018","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.smim.2022.101597_bib0635","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1038\/srep03113","article-title":"Increased tissue levels of omega-3 polyunsaturated fatty acids prevents pathological preterm birth","volume":"3","author":"Yamashita","year":"2013","journal-title":"Sci. Rep."},{"issue":"21","key":"10.1016\/j.smim.2022.101597_bib0640","doi-asserted-by":"crossref","first-page":"14190","DOI":"10.1021\/acs.joc.0c01701","article-title":"Synthesis of resolvin E3, a proresolving lipid mediator, and its deoxy derivatives: identification of 18-deoxy-resolvin E3 as a potent anti-inflammatory agent","volume":"85","author":"Fukuda","year":"2020","journal-title":"J. Org. Chem."},{"issue":"6","key":"10.1016\/j.smim.2022.101597_bib0645","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1254\/fpj.20044","article-title":"Resolvins as novel targets for rapid-acting antidepressants","volume":"155","author":"Deyama","year":"2020","journal-title":"Folia Pharmacol. Jpn."},{"issue":"17","key":"10.1016\/j.smim.2022.101597_bib0650","first-page":"1678","article-title":"Cardiovascular risk reduction with icosapent ethyl. reply","volume":"380","author":"Bhatt","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.smim.2022.101597_bib0655","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.plefa.2018.03.010","article-title":"Supplementation with eicosapentaenoic acid and docosahexaenoic acid reduces high levels of circulating proinflammatory cytokines in aging adults: a randomized, controlled study","volume":"132","author":"Tan","year":"2018","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"1","key":"10.1016\/j.smim.2022.101597_bib0660","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1161\/CIRCRESAHA.119.315506","article-title":"Enriched marine oil supplements increase peripheral blood specialized pro-resolving mediators concentrations and reprogram host immune responses: a randomized double-blind placebo-controlled study","volume":"126","author":"Souza","year":"2020","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.smim.2022.101597_bib0665","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202002471R","article-title":"Regression of human coronary artery plaque is associated with a high ratio of (18-hydroxy-eicosapentaenoic acid + resolvin E1) to leukotriene B(4)","volume":"35","author":"Welty","year":"2021","journal-title":"FASEB J."},{"key":"10.1016\/j.smim.2022.101597_bib0670","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2021.09.015","article-title":"Specialized proresolving mediators in symptomatic women with coronary microvascular dysfunction (from the women\u2019s ischemia trial to reduce events in nonobstructive CAD [WARRIOR] trial)","volume":"162","author":"Keeley","year":"2022","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.smim.2022.101597_bib0675","doi-asserted-by":"crossref","first-page":"9323","DOI":"10.1074\/jbc.M609212200","article-title":"Resolvin D1 and its aspirin-triggered 17R epimer: stereochemical assignments, anti-inflammatory properties and enzymatic inactivation","volume":"282","author":"Sun","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2022.101597_bib0680","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/nature08541","article-title":"Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis","volume":"461","author":"Spite","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.smim.2022.101597_bib0685","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.chembiol.2012.11.010","article-title":"Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents","volume":"20","author":"Dalli","year":"2013","journal-title":"Chem. Biol."},{"key":"10.1016\/j.smim.2022.101597_bib0690","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.plefa.2016.01.001","article-title":"Resolvin D3 multi-level proresolving actions are host protective during infection","volume":"138","author":"Norris","year":"2018","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"7","key":"10.1016\/j.smim.2022.101597_bib0695","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1021\/ol400484u","article-title":"Stereocontrolled total synthesis of the potent anti-inflammatory and pro-resolving lipid mediator resolvin D3 and its aspirin-triggered 17R-epimer","volume":"15","author":"Winkler","year":"2013","journal-title":"Org. Lett."},{"key":"10.1016\/j.smim.2022.101597_bib0700","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/JLB.3MI0617-254R","article-title":"Structural insights into Resolvin D4 actions and further metabolites via a new total organic synthesis and validation","volume":"103","author":"Winkler","year":"2018","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.smim.2022.101597_bib0705","doi-asserted-by":"crossref","first-page":"18972","DOI":"10.1038\/srep18972","article-title":"Resolvin D4 stereoassignment and its novel actions in host protection and bacterial clearance","volume":"6","author":"Winkler","year":"2016","journal-title":"Sci. Rep."},{"issue":"51","key":"10.1016\/j.smim.2022.101597_bib0710","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2116559118","article-title":"Human leukocytes selectively convert 4S,5S-epoxy-resolvin to resolvin D3, resolvin D4, and a cys-resolvin isomer","volume":"118","author":"Shay","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2022.101597_bib0715","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1182\/blood.2018886317","article-title":"Resolvin D4 attenuates the severity of pathological thrombosis in mice","volume":"134","author":"Cherpokova","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.smim.2022.101597_bib0720","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1182\/blood.2019002419","article-title":"Resolvin the clot: DVT resolution through RvD4","volume":"134","author":"Holinstat","year":"2019","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.smim.2022.101597_bib0725","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41569-019-0259-1","article-title":"Resolution of thrombus burden by targeting inflammatory mediators to treat DVT","volume":"16","author":"Huynh","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"issue":"7","key":"10.1016\/j.smim.2022.101597_bib0730","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1021\/acs.joc.8b00256","article-title":"Stereocontrolled synthesis of resolvin D4","volume":"83","author":"Morita","year":"2018","journal-title":"J. Org. Chem."},{"issue":"10","key":"10.1016\/j.smim.2022.101597_bib0735","doi-asserted-by":"crossref","first-page":"e00464","DOI":"10.1128\/IAI.00464-17","article-title":"Specialized proresolving mediators rescue infant mice from lethal Citrobacter rodentium infection and promote immunity against reinfection","volume":"85","author":"Diaz","year":"2017","journal-title":"Infect. Immun."},{"key":"10.1016\/j.smim.2022.101597_bib0740","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1016\/j.tetlet.2005.03.175","article-title":"First total synthesis of 7(S),17(S)-resolvin D5, a potent anti-inflammatory docosanoid","volume":"46","author":"Rodriguez","year":"2005","journal-title":"Tetrahedron Lett."},{"issue":"4","key":"10.1016\/j.smim.2022.101597_bib0745","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1021\/acs.joc.6b02870","article-title":"Total synthesis of resolvin D5","volume":"82","author":"Ogawa","year":"2017","journal-title":"J. Org. Chem."},{"issue":"7","key":"10.1016\/j.smim.2022.101597_bib0750","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1194\/jlr.RA120000777","article-title":"15-Lipoxygenase-1 biosynthesis of 7S,14S-diHDHA implicates 15-lipoxygenase-2 in biosynthesis of resolvin D5","volume":"61","author":"Perry","year":"2020","journal-title":"J. Lipid Res."},{"issue":"4","key":"10.1016\/j.smim.2022.101597_bib0755","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jacl.2018.03.091","article-title":"Identification of pro-resolving and inflammatory lipid mediators in human psoriasis","volume":"12","author":"Sorokin","year":"2018","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.smim.2022.101597_bib0760","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13054-017-1934-4","article-title":"Protracted immune disorders at one year after ICU discharge in patients with septic shock","volume":"22","author":"Rich\u00e9","year":"2018","journal-title":"Crit. Care"},{"key":"10.1016\/j.smim.2022.101597_bib0765","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3389\/fphar.2019.00745","article-title":"Resolvin D5 inhibits neuropathic and inflammatory pain in male but not female mice: distinct actions of D-series resolvins in chemotherapy-induced peripheral neuropathy","volume":"10","author":"Luo","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.smim.2022.101597_bib0770","doi-asserted-by":"crossref","first-page":"43079","DOI":"10.1074\/jbc.M509796200","article-title":"The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clustering","volume":"280","author":"Ariel","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"353","key":"10.1016\/j.smim.2022.101597_bib0775","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf7483","article-title":"Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses","volume":"8","author":"Chiurchiu","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.smim.2022.101597_bib0780","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.4049\/jimmunol.1200956","article-title":"Peroxisome proliferator-activated receptor gamma B cell-specific-deficient mice have an impaired antibody response","volume":"189","author":"Ramon","year":"2012","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2022.101597_bib0785","doi-asserted-by":"crossref","first-page":"17312","DOI":"10.1038\/s41598-021-96530-1","article-title":"Effect of resolvin D5 on T cell differentiation and osteoclastogenesis analyzed by lipid mediator profiling in the experimental arthritis","volume":"11","author":"Yamada","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.smim.2022.101597_bib0790","article-title":"Elovanoid-N32 or RvD6-isomer decrease ACE2 and binding of S protein RBD after injury or INF\u03b3 in the eye","author":"Pham","year":"2020","journal-title":"Res. Sq."},{"issue":"1","key":"10.1016\/j.smim.2022.101597_bib0795","doi-asserted-by":"crossref","first-page":"12787","DOI":"10.1038\/s41598-021-92293-x","article-title":"ELV-N32 and RvD6 isomer decrease pro-inflammatory cytokines, senescence programming, ACE2 and SARS-CoV-2-spike protein RBD binding in injured cornea","volume":"11","author":"Pham","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.smim.2022.101597_bib0800","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.TR120000954","article-title":"Docosanoid signaling modulates corneal nerve regeneration: effect on tear secretion, wound healing, and neuropathic pain","volume":"62","author":"Pham","year":"2021","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.smim.2022.101597_bib0805","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5966\/sctm.2015-0163","article-title":"Human periodontal stem cells release specialized proresolving mediators and carry immunomodulatory and prohealing properties regulated by lipoxins","volume":"5","author":"Cianci","year":"2016","journal-title":"Stem Cells Transl. Med."},{"issue":"8","key":"10.1016\/j.smim.2022.101597_bib0810","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100686R","article-title":"Elucidating the structure and functions of Resolvin D6 isomers on nerve regeneration with a distinctive trigeminal transcriptome","volume":"35","author":"Pham","year":"2021","journal-title":"FASEB J."},{"key":"10.1016\/j.smim.2022.101597_bib0815","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.prostaglandins.2005.04.004","article-title":"Rainbow trout (Oncorhynchus mykiss) brain cells biosynthesize novel docosahexaenoic acid-derived resolvins and protectins \u2013 mediator lipidomic analysis","volume":"78","author":"Hong","year":"2005","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.smim.2022.101597_bib0820","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.biochi.2020.08.015","article-title":"Eicosapentaenoic and docosahexaenoic acid derived specialised pro-resolving mediators: concentrations in humans and the effects of age, sex, disease and increased omega-3 fatty acid intake","volume":"178","author":"Calder","year":"2020","journal-title":"Biochimie"},{"key":"10.1016\/j.smim.2022.101597_bib0825","doi-asserted-by":"crossref","first-page":"11278","DOI":"10.1021\/jf202576k","article-title":"Baking reduces prostaglandin, resolvin, and hydroxy-fatty acid content of farm-raised Atlantic salmon (Salmo salar)","volume":"59","author":"Raatz","year":"2011","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.smim.2022.101597_bib0830","doi-asserted-by":"crossref","first-page":"8491","DOI":"10.1073\/pnas.0402531101","article-title":"Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress","volume":"101","author":"Mukherjee","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2022.101597_bib0835","doi-asserted-by":"crossref","first-page":"43807","DOI":"10.1074\/jbc.M305841200","article-title":"Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression","volume":"278","author":"Marcheselli","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2022.101597_bib0840","doi-asserted-by":"crossref","first-page":"15267","DOI":"10.1074\/jbc.M410638200","article-title":"A role for the mouse 12\/15-lipoxygenase pathway in promoting epithelial wound healing and host defense","volume":"280","author":"Gronert","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2022.101597_bib0845","doi-asserted-by":"crossref","first-page":"496","DOI":"10.4049\/jimmunol.178.1.496","article-title":"Protectin D1 is generated in asthma and dampens airway inflammation and hyper-responsiveness","volume":"178","author":"Levy","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2022.101597_bib0850","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.4049\/jimmunol.177.9.5902","article-title":"Resolvin D series and protectin D1 mitigate acute kidney injury","volume":"177","author":"Duffield","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2022.101597_bib0855","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1172\/JCI25420","article-title":"A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease","volume":"115","author":"Lukiw","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.smim.2022.101597_bib0860","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.4049\/jimmunol.176.3.1848","article-title":"Anti-inflammatory actions of neuroprotectin D1\/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes","volume":"176","author":"Serhan","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2022.101597_bib0865","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.chembiol.2011.06.008","article-title":"Novel proresolving aspirin-triggered DHA pathway","volume":"18","author":"Serhan","year":"2011","journal-title":"Chem. Biol."},{"key":"10.1016\/j.smim.2022.101597_bib0870","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bbalip.2014.08.006","article-title":"Protectins and maresins: new pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome","volume":"1851","author":"Serhan","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.smim.2022.101597_bib0875","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1096\/fj.11-201442","article-title":"Macrophage pro-resolving mediator maresin 1 stimulates tissue regeneration and controls pain","volume":"26","author":"Serhan","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.smim.2022.101597_bib0880","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1096\/fj.13-227728","article-title":"The novel 13S,14S-epoxy-maresin is converted by human macrophages to maresin1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H), and shifts macrophage phenotype","volume":"27","author":"Dalli","year":"2013","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.smim.2022.101597_bib0885","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102362","article-title":"Maresin biosynthesis and identification of maresin 2, a new anti-inflammatory and pro-resolving mediator from human macrophages","volume":"9","author":"Deng","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2022.101597_bib0890","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.ajpath.2015.12.012","article-title":"The Protectin PCTR1 is produced by human M2 macrophages and enhances resolution of infectious inflammation","volume":"186","author":"Ramon","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.smim.2022.101597_bib0895","doi-asserted-by":"crossref","first-page":"E4753","DOI":"10.1073\/pnas.1415006111","article-title":"Identification of sulfido-conjugated mediators that promote resolution of infection and organ protection","volume":"111","author":"Dalli","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2022.101597_bib0900","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.ajpath.2018.01.004","article-title":"Identification and complete stereochemical assignments of the new Resolvin Conjugates in Tissue Regeneration (RCTR) in human tissues that stimulate proresolving phagocyte functions and tissue regeneration","volume":"188","author":"de la Rosa","year":"2018","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.smim.2022.101597_bib0905","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1096\/fj.14-268441","article-title":"Novel proresolving and tissue regenerative resolvin and protectin sulfido-conjugated pathways","volume":"29","author":"Dalli","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.smim.2022.101597_bib0910","doi-asserted-by":"crossref","first-page":"12232","DOI":"10.1073\/pnas.1607003113","article-title":"Maresin conjugates in tissue regeneration biosynthesis enzymes in human macrophages","volume":"113","author":"Dalli","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.smim.2022.101597_bib0915","doi-asserted-by":"crossref","first-page":"13794","DOI":"10.1096\/fj.201902003R","article-title":"Biosynthetic metabolomes of cysteinyl-containing immunoresolvents","volume":"33","author":"Jouvene","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.smim.2022.101597_bib0920","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/EBC20200018","article-title":"Specialized pro-resolving mediator network: an update on production and actions","volume":"64","author":"Chiang","year":"2020","journal-title":"Essays Biochem."},{"key":"10.1016\/j.smim.2022.101597_bib0925","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.580117","article-title":"Non-inflammatory physiology of \u201cInflammatory\u201d mediators - unalamation, a new paradigm","volume":"11","author":"Maddipati","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2022.101597_bib0930","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.atherosclerosis.2020.11.018","article-title":"EPA and DHA differentially modulate monocyte inflammatory response in subjects with chronic inflammation in part via plasma specialized pro-resolving lipid mediators: a randomized, double-blind, crossover study","volume":"316","author":"So","year":"2021","journal-title":"Atherosclerosis"},{"issue":"22","key":"10.1016\/j.smim.2022.101597_bib0935","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1021\/acs.biochem.0c00931","article-title":"In vitro biosynthetic pathway investigations of neuroprotectin D1 (NPD1) and protectin DX (PDX) by human 12-lipoxygenase, 15-lipoxygenase-1, and 15-lipoxygenase-2","volume":"60","author":"Tsai","year":"2021","journal-title":"Biochemistry"},{"issue":"22","key":"10.1016\/j.smim.2022.101597_bib0940","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1056\/NEJMcibr1511280","article-title":"Resolvin infectious inflammation by targeting the host response","volume":"373","author":"Lee","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.smim.2022.101597_bib0945","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016311","article-title":"Lipid mediators in the resolution of inflammation","volume":"7","author":"Serhan","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.smim.2022.101597_bib0950","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2021.100943","article-title":"The need for precision nutrition, genetic variation and resolution in Covid-19 patients","volume":"77","author":"Simopoulos","year":"2021","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.smim.2022.101597_bib0955","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.4049\/jimmunol.1003865","article-title":"Cutting edge: humanized nano-proresolving medicines mimic inflammation-resolution and enhance wound healing","volume":"186","author":"Norling","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2022.101597_bib0960","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.actbio.2017.02.020","article-title":"Aspirin-Triggered Resolvin D1-modified materials promote the accumulation of pro-regenerative immune cell subsets and enhance vascular remodeling","volume":"53","author":"Sok","year":"2017","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.smim.2022.101597_bib0965","doi-asserted-by":"crossref","DOI":"10.1142\/S1793984417500027","article-title":"Pro-resolution potency of resolvins D1, D2 and E1 on neutrophil migration and in dermal wound healing","volume":"7","author":"Menon","year":"2017","journal-title":"Nano Life"},{"key":"10.1016\/j.smim.2022.101597_bib0970","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aan1471","article-title":"A cluster of immunoresolvents links coagulation to innate host defense in human blood","volume":"10","author":"Norris","year":"2017","journal-title":"Sci. Signal."},{"key":"10.1016\/j.smim.2022.101597_bib0975","article-title":"Stimulating the resolution of inflammation through Omega-3 polyunsaturated fatty acids in COVID-19: rationale for the COVID-Omega-F trial","volume":"11","author":"Arnardottir","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.smim.2022.101597_bib0980","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrd1383","article-title":"Inflammatory resolution: new opportunities for drug discovery","volume":"3","author":"Gilroy","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.smim.2022.101597_bib0985","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ni1276","article-title":"Resolution of inflammation: the beginning programs the end","volume":"6","author":"Serhan","year":"2005","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.smim.2022.101597_bib0990","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1161\/ATVBAHA.110.209908","article-title":"Resolvin E1 regulates adenosine diphosphate activation of human platelets","volume":"30","author":"Fredman","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1\u20132","key":"10.1016\/j.smim.2022.101597_bib0995","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.plefa.2010.09.002","article-title":"The endogenous pro-resolving mediators lipoxin A4 and resolvin E1 preserve organ function in allograft rejection","volume":"84","author":"Levy","year":"2011","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.smim.2022.101597_bib1000","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.expneurol.2017.11.005","article-title":"Combined administration of resolvin E1 and lipoxin A4 resolves inflammation in a murine model of Alzheimer\u2019s disease","volume":"300","author":"Kantarci","year":"2018","journal-title":"Exp. Neurol."},{"issue":"16","key":"10.1016\/j.smim.2022.101597_bib1005","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.117.032801","article-title":"ERV1\/ChemR23 signaling protects against atherosclerosis by modifying oxidized low-density lipoprotein uptake and phagocytosis in macrophages","volume":"138","author":"Laguna-Fernandez","year":"2018","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.smim.2022.101597_bib1010","doi-asserted-by":"crossref","first-page":"10621","DOI":"10.1073\/pnas.2005652117","article-title":"Resolvins resolve to heal mucosal wounds","volume":"117","author":"Colgan","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.smim.2022.101597_bib1015","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/jb\/mvs151","article-title":"Stereochemical assignment and anti-inflammatory properties of the omega-3 lipid mediator resolvin E3","volume":"153","author":"Isobe","year":"2013","journal-title":"J. Biochem."},{"issue":"11","key":"10.1016\/j.smim.2022.101597_bib1020","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1093\/carcin\/bgy117","article-title":"An omega-3 polyunsaturated fatty acid derivative, 18-HEPE, protects against CXCR4-associated melanoma metastasis","volume":"39","author":"Li","year":"2018","journal-title":"Carcinogenesis"},{"issue":"5","key":"10.1016\/j.smim.2022.101597_bib1025","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1084\/jem.172.5.1451","article-title":"Formation of lipoxins and leukotrienes during receptor-mediated interactions of human platelets and recombinant human granulocyte\/macrophage colony-stimulating factor-primed neutrophils","volume":"172","author":"Fiore","year":"1990","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.smim.2022.101597_bib1030","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1021\/bi00170a002","article-title":"Lipoxin biosynthesis by trout macrophages involves the formation of epoxide intermediates","volume":"33","author":"Rowley","year":"1994","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.smim.2022.101597_bib1035","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/emmm.201201891","article-title":"Toll-like receptor 7 stimulates production of specialized pro-resolving lipid mediators and promotes resolution of airway inflammation","volume":"5","author":"Koltsida","year":"2013","journal-title":"EMBO Mol. Med."},{"issue":"10","key":"10.1016\/j.smim.2022.101597_bib1040","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1096\/fj.201700319R","article-title":"GM-CSF- and M-CSF-primed macrophages present similar resolving but distinct inflammatory lipid mediator signatures","volume":"31","author":"Lukic","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.smim.2022.101597_bib1045","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1096\/fj.10-170027","article-title":"Eosinophils promote resolution of acute periotonitis by producing proresolving mediators in mice","volume":"25","author":"Yamada","year":"2011","journal-title":"FASEB J."},{"issue":"12","key":"10.1016\/j.smim.2022.101597_bib1050","doi-asserted-by":"crossref","first-page":"6378","DOI":"10.4049\/jimmunol.1202969","article-title":"Inhaled carbon monoxide accelerates resolution of inflammation via unique proresolving mediator-heme oxygenase-1 circuits","volume":"190","author":"Chiang","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2022.101597_bib1055","series-title":"Lipoxygenases and Their Products","first-page":"235","article-title":"Lipoxins: bioactive lipoxygenase interaction products","author":"Dahl\u00e9n","year":"1991"},{"issue":"9","key":"10.1016\/j.smim.2022.101597_bib1060","doi-asserted-by":"crossref","first-page":"12492","DOI":"10.1096\/fj.202000483R","article-title":"Eosinophils promote corneal wound healing via the 12\/15-lipoxygenase pathway","volume":"34","author":"Ogawa","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.smim.2022.101597_bib1065","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.4049\/jimmunol.178.6.3912","article-title":"Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation","volume":"178","author":"Arita","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2022.101597_bib1070","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.4049\/jimmunol.180.5.3512","article-title":"Resolvin E1 metabolome in local inactivation during inflammation-resolution","volume":"180","author":"Hong","year":"2008","journal-title":"J. Immunol."}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532322000148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532322000148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:39:35Z","timestamp":1778582375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044532322000148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":214,"alternative-id":["S1044532322000148"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2022.101597","relation":{},"ISSN":["1044-5323"],"issn-type":[{"value":"1044-5323","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition","name":"articletitle","label":"Article Title"},{"value":"Seminars in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smim.2022.101597","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101597"}}